HomeAI · summaries
Storia in 9 fonti
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
CVS obesity drug deal puts Lilly on equal footing with Novo
The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.
- ·
nbcnews.com
CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
The pharmacy benefits manager also plans to add the weight loss pill Foundayo to its formulary next month.
- ·
morningstar.com
Foundayo and Zepbound now covered for millions of Americans
Foundayo and Zepbound now covered for millions of Americans
- ·
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications with Expanded Coverage Options
- ·
cnbc.com
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
- ·
qz.com
CVS Caremark adds Zepbound and Foundayo to formulary
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be co-preferred options
- ·
independent.co.uk
CVS expands access to blockbuster weight-drugs in surprise reversal
This move marks a pivotal shift for patients seeking access to these highly sought-after treatments
- ·
fiercepharma.com
CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will
- ·
endpoints.news
Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook
Lilly's Foundayo and Zepbound gain CVS Caremark formulary coverage, expanding access for 90 million members at $25 monthly co-pays.
- ·
upi.com
CVS Caremark to cover Foundayo, Zepbound obesity drugs - UPI.com
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.